Dr. Colin Wheeler

Vice President, European Regulatory Affairs

Dr. Colin Wheeler is the Vice President of European Regulatory Affairs at ProPharma Group. Dr. Wheeler has worked in the global pharmaceutical industry for over 20 years in Regulatory and Clinical Development roles. Colin was previously CEO and founder of Southwood Research Ltd, a UK and Netherlands based consultancy company within the fields of Regulatory and Development Sciences, which he founded in 2016. Southwood Research was acquired by ProPharma Group in 2019.

Colin is a UK certified physician and has worked in various global roles in across companies such as Merck, Takeda and Celgene, including time spent working both in the EU and US. He has worked extensively in the areas of Hematology and Oncology, and has a particular interest in Paediatric and Orphan Diseases. Colin has broad experience of presenting to global regulatory agencies including the EMA, FDA and PMDA. Colin qualified in Medicine (MBChB) from Glasgow University, and has a post graduate diploma in Pharmaceutical Medicine (DipPharmMed) from the University of Cardiff. Colin is a fellow of the Faculty of Pharmaceutical Medicine (FFPM).

Company Blog

November 11, 2019
Three Steps Towards Fulfilling the EMA Nitrosamine Advice
How a results-driven, chemistry-based strategy will enable companies to meet MAH responsibilities with the… Read More
November 7, 2019
Meet the Expert: Hannah Hunter
Hear from Hannah Hunter, Associate Director of MI Operations based in our Richmond, North… Read More
October 16, 2019
Meet the Expert: Xenia Freifrau von Maltzan
Hear from our Berlin colleague, Xenia von Maltzan, on her perspective of the medical… Read More
More Articles

UPCOMING Events

November 20, 2019
DIA European Medical Information and Communications Conference
This unique meeting is organised by medical information professionals for medical information professionals. T... Read More
December 04, 2019
Cannabiz Innovation Hub
Join us for a unique platform to debate best practices that are imperative to enabling scale, efficiency and i... Read More
All Events
Contact Us